Peer-reviewedLicence not statedOncology Letters13 Oct 2026

Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis

Gai Liang¹
Qu Zhang¹
Mengting Yuan¹
Guojun Yao¹
Feng Yuan^2,3

¹Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China
²Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China
³National Key Clinical Specialty, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for Breast Cancer, Wuhan, Hubei 430079, P.R. China

Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
Translational cancer research19 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Impact of Suture Configurations for Posterior Horn Meniscal Repair on Postoperative Stability and Reoperation Rates in Patients Undergoing Concurrent Anterior Cruciate Ligament Reconstruction: A Retrospective Comparative Study
Yongwei Song, Kexin Cai, Jiachao Qiu +3
Indian journal of orthopaedics6 Jun 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Sentinel lymph node-guided modification of postoperative radiotherapy in oral tongue squamous cell carcinoma: a retrospective dosimetric and NTCP modelling study.
Einar Björgvinsson, Aeneas Kolev, Eva Onjukka +7
Clinical and translational radiation oncology8 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
Huaxi Fan, Rong Yu, Guishu Wu +6
Journal of hepatocellular carcinoma28 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
A Systematic Review and Meta-Analysis: Does Molecular Hydrogen Exert Radioprotective Effects Without Compromising the Antitumor Efficacy of Radiotherapy or Concurrent Chemoradiotherapy?
Yu Ivy Zhang, Michiko Miyakawa, Ayako Miyakawa
Cureus19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{liang2026safety,
  title = {{Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis}},
  author = {Gai Liang and Qu Zhang and Mengting Yuan and Guojun Yao and Feng Yuan},
  journal = {Oncology Letters},
  year = {2026},
  month = oct,
  doi = {10.3892/ol.2026.15903},
  url = {https://doi.org/10.3892/ol.2026.15903},
}

RIS

TY  - JOUR
TI  - Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
AU  - Gai Liang
AU  - Qu Zhang
AU  - Mengting Yuan
AU  - Guojun Yao
AU  - Feng Yuan
PY  - 2026
DA  - 2026/10/13
JO  - Oncology Letters
DO  - 10.3892/ol.2026.15903
UR  - https://doi.org/10.3892/ol.2026.15903
SN  - 1792-1074
SN  - 1792-1082
ER  -

Related

Cite